Reolysin reovirus: ONC began a North American Phase I/II trial in about 38 patients with recurrent malignant glioma.

Oncolytics Biotech Inc. (TSE:ONC; ONCY),

Read the full 56 word article

How to gain access

Continue reading with a
two-week free trial.